CATHERINE CASEY: Open Payments
NPI 1861482739 · GENTRY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 23 payments from 9 companies in 2025. Trend: 2023 $1,201 · 2024 $686 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $207 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 3 | $51 |
| Dexcom, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: AIRSUPRA, Ozempic, Dexcom G6 Transmitter, JARDIANCE, FARXIGA, MOUNJARO, BREZTRI, FANAPT.
Industry payments across AR — which companies pay providers there.
